These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9601580)

  • 21. Antiarrhythmic effect of antazoline in experimental models of acquired short- and long-QT-syndromes.
    Ellermann C; Sterneberg M; Kochhäuser S; Dechering DG; Fehr M; Eckardt L; Frommeyer G
    Europace; 2018 Oct; 20(10):1699-1706. PubMed ID: 29377987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tedisamil and dofetilide-induced torsades de pointes, rate and potassium dependence.
    Barrett TD; Hennan JK; Fischbach PS; O'Neill BP; Driscoll EM; Lucchesi BR
    Br J Pharmacol; 2001 Apr; 132(7):1493-500. PubMed ID: 11264243
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Noninvasive cardiac activation imaging of ventricular arrhythmias during drug-induced QT prolongation in the rabbit heart.
    Han C; Pogwizd SM; Killingsworth CR; Zhou Z; He B
    Heart Rhythm; 2013 Oct; 10(10):1509-15. PubMed ID: 23773986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RSD1235 blocks late INa and suppresses early afterdepolarizations and torsades de pointes induced by class III agents.
    Orth PM; Hesketh JC; Mak CK; Yang Y; Lin S; Beatch GN; Ezrin AM; Fedida D
    Cardiovasc Res; 2006 Jun; 70(3):486-96. PubMed ID: 16545351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prophylactic magnesium to decrease the arrhythmogenic potential of class III antiarrhythmic agents in a rabbit model.
    White CM; Xie J; Chow MS; Kluger J
    Pharmacotherapy; 1999 May; 19(5):635-40. PubMed ID: 10331827
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperventilation assists proarrhythmia development during delayed repolarization in clofilium-treated, anaesthetized, mechanically ventilated rabbits.
    Papp H; Sarusi A; Farkas AS; Takacs H; Kui P; Vincze D; Ivany E; Varro A; Papp JG; Forster T; Farkas A
    J Physiol Pharmacol; 2016 Oct; 67(5):731-737. PubMed ID: 28011953
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Severe proarrhythmic potential of risperidone compared to quetiapine in an experimental whole-heart model of proarrhythmia.
    Frommeyer G; von der Ahe H; Brücher B; Dechering DG; Lange PS; Reinke F; Wasmer K; Köbe J; Pott C; Mönnig G; Eckardt L
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1073-80. PubMed ID: 27405774
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts.
    Gerhardy A; Scholtysik G; Schaad A; Haltiner R; Hess T
    Basic Res Cardiol; 1998 Aug; 93(4):285-94. PubMed ID: 9782371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872.
    Bril A; Gout B; Bonhomme M; Landais L; Faivre JF; Linee P; Poyser RH; Ruffolo RR
    J Pharmacol Exp Ther; 1996 Feb; 276(2):637-46. PubMed ID: 8632331
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beat-to-Beat variability of repolarization determines proarrhythmic outcome in dogs susceptible to drug-induced torsades de pointes.
    Thomsen MB; Volders PG; Beekman JD; Matz J; Vos MA
    J Am Coll Cardiol; 2006 Sep; 48(6):1268-76. PubMed ID: 16979017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of torsades de pointes in rabbit ventricles perfused with sedating and nonsedating histamine H1-receptor antagonists.
    Gilbert JD; Cahill SA; McCartney DG; Lukas A; Gross GJ
    Can J Physiol Pharmacol; 2000 May; 78(5):407-14. PubMed ID: 10841436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts.
    Kui P; Orosz S; Takács H; Sarusi A; Csík N; Rárosi F; Csekő C; Varró A; Papp JG; Forster T; Farkas AS; Farkas A
    J Pharmacol Toxicol Methods; 2016; 80():26-34. PubMed ID: 27063345
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vitro electrophysiologic and proarrhythmic effects of amiodarone and sotalol in a rabbit model of acute atrioventricular block.
    Milberg P; Ramtin S; Mönnig G; Osada N; Wasmer K; Breithardt G; Haverkamp W; Eckardt L
    J Cardiovasc Pharmacol; 2004 Sep; 44(3):278-86. PubMed ID: 15475823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progesterone pretreatment reduces the incidence of drug-induced torsades de pointes in atrioventricular node-ablated isolated perfused rabbit hearts.
    Tisdale JE; Jaynes HA; Overholser BR; Sowinski KM; Kovacs RJ
    J Cardiovasc Electrophysiol; 2019 Jun; 30(6):941-949. PubMed ID: 31006943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prolonged action potential durations, increased dispersion of repolarization, and polymorphic ventricular tachycardia in a mouse model of proarrhythmia.
    Fabritz L; Kirchhof P; Franz MR; Eckardt L; Mönnig G; Milberg P; Breithardt G; Haverkamp W
    Basic Res Cardiol; 2003 Feb; 98(1):25-32. PubMed ID: 12494266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessment of the proarrhythmic potential of the novel antiarrhythmic agent AZD7009 and dofetilide in experimental models of torsades de pointes.
    Wu Y; Carlsson L; Liu T; Kowey PR; Yan GX
    J Cardiovasc Electrophysiol; 2005 Aug; 16(8):898-904. PubMed ID: 16101634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Potassium and calcium current blocking properties of the novel antiarrhythmic agent H 345/52: implications for proarrhythmic potential.
    Amos GJ; Abrahamsson C; Duker G; Hondeghem L; Palmer M; Carlsson L
    Cardiovasc Res; 2001 Feb; 49(2):351-60. PubMed ID: 11164845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias.
    Belardinelli L; Liu G; Smith-Maxwell C; Wang WQ; El-Bizri N; Hirakawa R; Karpinski S; Li CH; Hu L; Li XJ; Crumb W; Wu L; Koltun D; Zablocki J; Yao L; Dhalla AK; Rajamani S; Shryock JC
    J Pharmacol Exp Ther; 2013 Jan; 344(1):23-32. PubMed ID: 23010360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antifibrillatory effects of clofilium in the rabbit isolated heart.
    Friedrichs GS; Chi L; Green AL; Lucchesi BR
    Br J Pharmacol; 1994 Sep; 113(1):209-15. PubMed ID: 7812612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental models of torsades de pointes.
    Weissenburger J; Davy JM; Chézalviel F
    Fundam Clin Pharmacol; 1993; 7(1):29-38. PubMed ID: 8458600
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.